Skip Navigation
Skip to contents

IMKASID 2024

Applications for GO IMKASID will no longer be accepted.

The International Meeting on intestinal diseases in conjunction with the annual congress of the Korean Association for the Study of Intestinal Diseases (IMKASID) has been held in Korea either annually or biennially since 2016. The program for young enthusiastic Asian doctors, GO IMKASID (Great Opportunity for collaboration in IMKASID) has been launched in 2019 firstly. So, on behalf of the KASID and the organizing committee of IMKASID, we would like to invite young doctors from Asia to apply for GO IMKASID and IMKASID 2024.

GO IMKASID program is intended to promote advancement and collaboration among participating Asian societies of intestinal diseases. By participating in this program, we expect doctors outside Korea to be able to acquire and develop new knowledge and technical skills about inflammatory bowel diseases, colorectal tumors, advanced colonoscopy and small bowel endoscopy at outstanding training centers in Korea. The training centers will help participating trainees to acquire clinical skills and academic knowledge through interesting case conferences, laboratory meeting, ward rounding/expert meetings and therapeutic endoscopy, etc. We wish the experience in GO IMKASID motivate the participants to improve themselves as researchers and clinicians after coming back to their region. For the GO IMKASID awardees, a grant (USD 1,500) will be given to each trainee to cover travel expenses, and accommodation costs (benefits to the awardees are described in detail at the bottom).

GO IMKASID will be held from April 8 (Mon) to 9 (Tue), 2024 at each training hospital before IMKASID 2024. In addition to the training program, participants of GO IMKASID are invited to IMKASID 2024, which will be held from April 11 (Thu) to 13 (Sat), 2024 in Seoul, Korea. We encourage all young doctors from Asian countries to take an active interest and participate in this program.

Key Dates

  • Deadline for submission of application has been extended to January 5, 2024.
  • Awardees will be notified after January 22, 2024.
  • GO IMKASID 2024: April 8~9, 2024

Eligibility

Young Asian doctors interested in inflammatory bowel diseases, colorectal neoplasia, and colonoscopic procedure, not residing in Korea under the age of 40 (year of birth: 1984
or after) are eligible to apply.
* All applicants must be able to communicate in English.

Target Fields

Inflammatory bowel disease, colorectal cancer, colorectal polyp, colorectal endoscopic submucosal dissection

Number of Awardees

30 People

Benefits

  • USD 1,500 grant to cover airfare, domestic transport, accommodation, meals, visa application, and travel insurance.
    * It is the responsibility of the applicant to obtain their visa and travel insurance.
    * GO IMKASID awardees are not eligible for Academic Grants and Travel Grants.
  • 3-day training program at outstanding centers in Korea

Duties (Besides Training)

  • All selected trainees must attend IMKASID 2024. Full registration fees for IMKASID 2024 (except IUS workshop on April 11, 2024) will be waived.
  • Submission of evaluation sheets after training

Guidelines for Application

  • The International Academic Exchange Committee of KASID will select grant recipients and place those in selected training centers.
  • Required documents
    • Application form including a recent photo
    • Recommendation letter in English: one from the applicants’ training preceptor/director
    • A passport photocopy showing the photograph and identification information

[Optional] Test score of an English proficiency test: TOEIC, TOEFL, IELTS, G-TELP, etc.
* Any kind of internationally recognized English language test score or certificate can be submitted.
[Optional] Abstract submission to IMKASID 2024

Those who submit abstract for IMKASID 2024 will be given priority for GO IMKASID.

Contact & Submission Information

Please check the contact & submission information on the application form.

Diamond
  • abbvie
  • CELLTRION PHARM
  • Jassen
  • SAMSUNG BIOEPIS
  • Takeda
Platinum
  • Bristrol Myers Squibb
  • DEAWOONG
  • FERRING PHARMACEUTICALS
Gold
  • Eisasi Korea Inc.
  • Pfizer
Bronze
  • GSK
  • Pharmbio Korea Inc.
  • TAEJOON

Go Top

Korean Association for the Study of Intestinal Diseases
31, Seolleung-ro 86 Gil, Gangnam-Gu, Seoul, 06193, Korea
IMKASID 2024 Secretariat [People-x, Inc.]
  • 1F, Haeoreum B/D, 16, Yeoksam-ro 17-gil, Gangnam-gu, Seoul, 06246, Korea
    [All Inquiries] info@imkasid.kr
    [Scientific Program/Abstract] +82-2-566-5951
    [Registration] +82-70-4895-6139
    [Sponsorship] +82-70-4895-6110

Copyright ⓒ Korean Association for the Study of Intestinal Diseases All rights reserved